In
silico Docking Approach of Coumarin Derivatives as an Aromatase Antagonist
Reshma
Thomas, R. Hari, Josna Joy, Saranya Krishnan, Swathy A.N, Sruthy. S. Nair,
Asha
Asokan Manakadan, Sathianarayanan, Saranya T.S*
Department
of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa
Vidyapeetham University, AIMS Health Sciences Campus, Ponekkara P. O., Kochi –
682041, Kerala, India
*Corresponding Author E-mail: saranyats19347@aims.amrita.edu
ABSTRACT:
Coumarins are pharmacologically
active moiety well known for their wide variety of activities. Coumarin is the
combination of benzene and pyrone ring and it belongs to benzo pyrone family.
It is available from plants, microorganisms etc. Depending on various
substitutions on different positions of coumarin, we get different
pharmacological properties like anticancer, antioxidant, antifungal,
anti-inflammatory, antiviral, anticoagulant etc. The purpose of this study is to carry out the
docking studies of coumarin derivatives containing electrophilic and
nucleophilic substitutions with the anticancer target aromatase by using
Arguslab version 4.0.1. Fifty four lead molecules were designed and their
docking scores were compared with the standard drug Gefitinib. The validation
of ligands were performed using Lipinski rule of five. It was observed that
nineteen ligands showed better docking score than the standard drug Gefitinib.
Phytoconstituents like Isofraxidin,
Scopoletin and umbelliferone from
Compositae family, which were the source of coumarin nucleus were also taken
for the docking analysis. It was observed that most of the lead molecules
showed higher docking score than the phytoconstituents.
KEYWORDS:
Coumarin, Aromatase, Docking, Arguslab, Gefitinib
INTRODUCTION:
Coumarin belongs to benzo pyron
family with class name of coumaro, the
vernacular name of tonka bean (Dipeteryx
odorata willd, Fabaceae) from
which coumarin was isolated in 1820 [1-3]. Various coumarin
derivatives are present in plant kingdom, coumarins are mostly found in
essential oils found in cinnamon bark, cassia leaf, lavnder etc. They are also
obtained from fruits like bilberry, cloudberry etc. Most of the coumarins are
present in higher plants, and widely available from Rutaceae and umbilliferone
family [4]. Some of the members of coumarins are also discovered
from microorganisms, like novobiocin and coumermycin from streptomyces and
aflatoxin from Aspergillus species.
Coumarins can be synthesized in
lab by various chemical reactions and depending upon different substitutions on coumarin it will produce
derivatives with different biological activities like antimicrobial,
antioxidant, anticoagulant, antiviral, anti-inflammatory, anticancer etc[5-13].
Aromatase is an enzyme belonging to cytochrome p450 family. It has been
observed that the main cause of breast cancer is increase in the level of
estrogen. Researches in this field denotes that, coumarin have inhibitory
activity on aromatase, which is a key enzyme in the biosynthesis of estrogen
from androgen[14]. Therefore, the objective of the study was to
develop coumarin derivatives and to check their potency and toxicity against
the known cancer targets.
Fig 1: Chemical structure of coumarin nucleus
MATERIALS AND METHODS:
Fifty four lead molecules were
designed by using chemsketch by giving substitutions on 3rd, 4th, 5th,
6th, 7th and 8th positions of coumarin nucleus
as shown in fig:1. In this study gefitinib was selected as the reference drug, which
is an anticancer drug [15].
Docking study:
Molecular docking:
Docking is a method, which
predicts the preferred orientation of one molecule to a second when bound to
each other to form a stable complex. Here the docking was performed using the
software Argus lab 4.0.1. All the water molecules in the protein were removed
and docked with designed ligands to check the affinity expressed in terms of
the docking score. Then the ligand score was compared with the score of
reference drug to determine the efficiency of the designed lead molecules.
RESULTS
AND DISCUSSION:
Table
1. Analysis of Lipinski Rule of Five for novel proposed analogues of coumarin
Sl. No |
Name of the compound |
Molecular weight |
No. of Hba |
No. of Hbd |
C log p |
No of Rot. b |
No. of violations |
1 |
3- Bromo
Coumarin |
225.041 |
2 |
0 |
2.751 |
0 |
0 |
2 |
4- Bromo Coumain |
225.041 |
2 |
0 |
2.751 |
0 |
0 |
3 |
5-Bromo Coumarin |
225.041 |
2 |
0 |
2.775 |
0 |
0 |
4 |
6-Bromo Coumarin |
225.041 |
2 |
0 |
2.799 |
0 |
0 |
5 |
7-Bromo Coumarin |
225.041 |
2 |
0 |
2.799 |
0 |
0 |
6 |
8-Bromo Coumarin |
225.041 |
2 |
0 |
2.775 |
0 |
0 |
7 |
3-Chloro
Coumarin |
180.59 |
2 |
0 |
2.62 |
0 |
0 |
8 |
4- Chloro
Coumarin |
180.59 |
2 |
0 |
2.62 |
0 |
0 |
9 |
5-Chloro
Coumarin |
180.59 |
2 |
0 |
2.64 |
0 |
0 |
10 |
6-Chloro
Coumarin |
180.59 |
2 |
0 |
2.668 |
0 |
0 |
11 |
7-Chloro
Coumarin |
180.59 |
2 |
0 |
2.668 |
0 |
0 |
12 |
8-Chloro
Coumarin |
180.59 |
2 |
0 |
2.64 |
0 |
0 |
13 |
3- Fluoro
Coumarin |
164.135 |
2 |
0 |
1.133 |
0 |
0 |
14 |
4- Fluoro
Coumarin |
164.135 |
2 |
0 |
2.105 |
0 |
0 |
15 |
5- Fluoro
Coumarin |
164.135 |
2 |
0 |
2.129 |
0 |
0 |
16 |
6- Fluoro
Coumarin |
164.135 |
2 |
0 |
1.181 |
0 |
0 |
17 |
7- Fluoro
Coumarin |
164.135 |
2 |
0 |
2.153 |
0 |
0 |
18 |
8- Fluoro
Coumarin |
164.135 |
2 |
0 |
2.129 |
0 |
0 |
19 |
3- Iodo Coumarin |
272.041 |
2 |
0 |
3.025 |
0 |
0 |
20 |
4-Iodo Coumarin |
272.041 |
2 |
0 |
3.025 |
0 |
0 |
21 |
5-Iodo Coumarin |
272.041 |
2 |
0 |
3.049 |
0 |
0 |
22 |
6-Iodo Coumarin |
272.04 |
2 |
0 |
3.073 |
0 |
0 |
23 |
7-Iodo Coumarin |
272.04 |
2 |
0 |
3.073 |
0 |
0 |
24 |
8-Iodo Coumarin |
272.041 |
2 |
0 |
3.049 |
0 |
0 |
25 |
3-Hydroxy
Coumarin |
162.14 |
3 |
1 |
1.723 |
0 |
0 |
26 |
4- Hydroxy
Coumarin |
162.14 |
3 |
1 |
1.723 |
0 |
0 |
27 |
5 -Hydroxy
Coumarin |
162.14 |
3 |
1 |
1.747 |
0 |
0 |
28 |
6 -Hydroxy
Coumarin |
162.14 |
3 |
1 |
1.511 |
0 |
0 |
29 |
7-Hydroxy
Coumarin |
162.14 |
3 |
1 |
1.511 |
0 |
0 |
30 |
8-Hydroxy
Coumarin |
162.14 |
2 |
0 |
1.511 |
0 |
0 |
31 |
3-MethoxyCoumarin |
176.171 |
3 |
0 |
1.998 |
0 |
0 |
32 |
4-Methoxy
Coumarin |
176.171 |
3 |
0 |
1.998 |
0 |
0 |
33 |
5-Methoxy
Coumarin |
176.171 |
3 |
0 |
2.022 |
0 |
0 |
34 |
6-Methoxy
Coumarin |
176.171 |
3 |
0 |
2.046 |
0 |
0 |
35 |
7-Methoxy
Coumarin |
176.171 |
3 |
0 |
2.046 |
0 |
0 |
36 |
8-MethoxyCoumarin |
176.171 |
3 |
0 |
2.022 |
0 |
0 |
37 |
3- Ethoxy
Coumarin |
190.18 |
3 |
0 |
2.374 |
0 |
0 |
38 |
4-Ethoxy
Coumarin |
190.18 |
3 |
0 |
2.374 |
0 |
0 |
39 |
5-Ethoxy
Coumarin |
190.18 |
3 |
0 |
2.398 |
0 |
0 |
40 |
6-Ethoxy
Coumarin |
190.18 |
3 |
0 |
2.422 |
0 |
0 |
41 |
7-Ethoxy
Coumarin |
190.18 |
3 |
0 |
2.422 |
0 |
0 |
42 |
8-Ethoxy Coumarin |
190.18 |
3 |
0 |
2.422 |
0 |
0 |
43 |
3- Nitro
Coumarin |
191.14 |
5 |
0 |
1.901 |
0 |
0 |
44 |
4 -Nitro
Coumarin |
191.14 |
5 |
0 |
1.901 |
0 |
0 |
45 |
5- Nitro
Coumarin |
191.14 |
5 |
0 |
1.901 |
0 |
0 |
46 |
6 -Nitro
Coumarin |
191.14 |
5 |
0 |
1.901 |
0 |
0 |
47 |
7 -Nitro
Coumarin |
191.14 |
5 |
0 |
1.901 |
0 |
0 |
48 |
8 -Nitro Coumarin |
191.14 |
5 |
0 |
1.901 |
0 |
0 |
49 |
2oxo-2H-chromene-3-carbaldehyde |
174.155 |
3 |
0 |
1.732 |
0 |
0 |
50 |
2oxo-2H-chromene-4-carbaldehyde |
174.155 |
3 |
0 |
1.732 |
0 |
0 |
51 |
2oxo-2H-chromene-5-carbaldehyde |
174.155 |
3 |
0 |
1.732 |
0 |
0 |
52 |
2oxo-2H-chromene-6-carbaldehyde |
174.155 |
3 |
0 |
1.732 |
0 |
0 |
53 |
2oxo-2H-chromene-7-carbaldehyde |
174.155 |
3 |
0 |
1.732 |
0 |
0 |
54 |
2oxo-2H-chromene-8-carbaldehyde |
174.155 |
3 |
0 |
1.732 |
0 |
0 |
|
Phytoconstituents |
|
|
|
|
|
|
1 |
Isofraxidin |
222.2 |
5 |
1 |
1.54 |
2 |
0 |
2 |
Scopoletin |
192.17 |
4 |
1 |
1.33 |
1 |
0 |
3 |
Umbilliserone |
176.17 |
3 |
1 |
1.89 |
0 |
0 |
Selection of target:
The target selected was the
aromatase inhibitor having PDB id 3S7S as the target [16].
Preparation of ligands:
The ligands were designed and
their smiles notations were obtained from ChemSketch, which is a chemically
intelligent drawing, interface freeware developed by Advanced Chemistry
Department. The designed ligands were saved in PDB format, which is acceptable
to all docking software.
Validation of ligands
The molecular properties based on Lipinski rule of five and the drug
ADME were checked using the software Molinspiration, the results are compiled
in the Table 1 and 2.
The results of the validation of ligands shows that the values of
all fifty four compounds and three phytoconstituents based on molecular weight
is less than 500 Daltons, number of hydrogen bond donors and hydrogen bond
acceptors are below 5 and 10, partition coefficient lies within the limits of
5. The results shows that there is no violation of Lipinski rule of five.
Bioactivity study:
Table 2. Bioactivity results
of proposed analogues of coumarin
Sl no |
Name of compound |
GPCR ligand |
Ion channel modulator |
Kinase inhibitor |
Nuclear receptor ligand |
Protease inhibitor |
Enzyme inhibitor |
1 |
3-Bromo Coumarin |
-1.37 |
-0.83 |
-1.29 |
-1.21 |
-1.35 |
-0.58 |
2 |
4-Bromo Coumain |
-1.29 |
-0.93 |
-1.19 |
-1.10 |
-1.36 |
-0.54 |
3 |
5-Bromo Coumarin |
-1.34 |
-0.97 |
-1.29 |
-1.35 |
-1.44 |
-0.57 |
4 |
6-Bromo Coumarin |
-1.63 |
-1.52 |
-1.46 |
-1.54 |
-1.55 |
-0.66 |
5 |
7-Bromo Coumarin |
-1.63 |
-0.91 |
-1.61 |
-1.63 |
-1.68 |
-1.69 |
6 |
8-Bromo Coumarin |
-1.49 |
-1.03 |
-1.59 |
-1.42 |
-1.43 |
-0.53 |
7 |
3-Chloro
Coumarin |
-1.45 |
-1 |
-1.48 |
-1.27 |
-1.33 |
-1.58 |
8 |
4-Chloro
Coumarin |
-1.29 |
-1.65 |
-1.26 |
-1.08 |
-1.31 |
-1.55 |
9 |
5-Chloro
Coumarin |
-1.30 |
--0.67 |
-1.36 |
-1.29 |
-1.36 |
-0.57 |
10 |
6-Chloro
Coumarin |
-1.27 |
-0.75 |
-1.40 |
-1.26 |
-1.32 |
-1.53 |
11 |
7-Chloro
Coumarin |
-1.24 |
-0.65 |
--1.53 |
-1.21 |
-1.35 |
-0.53 |
12 |
8-Chloro
Coumarin |
-1.45 |
-1 |
-1.48 |
-1.27 |
-1.33 |
-.0.52 |
13 |
3- Fluoro
Coumarin |
-1.13 |
-0.71 |
-1.32 |
-1.23 |
-1.37 |
-0.60 |
14 |
4- Fluoro
Coumarin |
-1.13 |
-0.69 |
-1.06 |
-0.92 |
-1.22 |
-0.46 |
15 |
5- Fluoro
Coumarin |
-1.13 |
-0.71 |
-1.14 |
--1.12 |
-1.29 |
-0.40 |
16 |
6- Fluoro
Coumarin |
-1.20 |
-0.75 |
-1.30 |
-1.15 |
-1.33 |
-0.47 |
17 |
7- Fluoro
Coumarin |
-1.09 |
-0.65 |
-1.25 |
-1.26 |
-1.27 |
-0.46 |
18 |
8- Fluoro
Coumarin |
-1.29 |
-0.67 |
-1.30 |
-1.01 |
-1.33 |
-0.42 |
19 |
3-Iodo Coumarin |
-1.24 |
-0.60 |
-1.17 |
-0.96-1. |
-1.27 |
-0.53 |
20 |
4-Iodo Coumarin |
-1.16 |
-0.67 |
-1.07 |
-0.99 |
-1.23 |
-0.57 |
21 |
5-Iodo Coumarin |
-1.26 |
-0.70 |
-1.04 |
-1.19 |
-1.29 |
-0.60 |
22 |
6-Iodo Coumarin |
-1.31 |
-0.69 |
-1.26 |
-1.19 |
--1.44 |
-0.59 |
23 |
7-Iodo Coumarin |
-1.31 |
-0.69 |
-1.26 |
-1.19 |
-1.44 |
-0.59 |
24 |
8-Iodo Coumarin |
-1.24 |
-0.71 |
-1.32 |
-0.23 |
-1.37 |
-0.60 |
25 |
3-Hydroxy
Coumarin |
-1.11 |
-0.59 |
-1.13 |
-0.78 |
-1.14 |
-0.23 |
26 |
4-Hydroxy
Coumarin |
-1.29 |
-0.49 |
-1.51 |
-1.02 |
-1.08 |
-0.27 |
27 |
5-Hydroxy
Coumarin |
-1.21 |
-0.59 |
-1.32 |
-1.12 |
-1.17 |
-0.28 |
28 |
6-Hydroxy
Coumarin |
-1.15 |
-0.64 |
-1.22 |
-0.69 |
-1.26 |
-0.23 |
29 |
7-Hydroxy
Coumarin |
-1.22 |
-0.72 |
-1.30 |
-0.92 |
-1.30 |
-0.35 |
30 |
8-Hydroxy
Coumarin |
-1.02 |
-0.64 |
-1.30 |
-1.11 |
-1.12 |
-0.24 |
31 |
3-MethoxyCoumarin |
-1.08 |
-0.67- |
-1.05 |
-0.86 |
-1.12 |
-0.31 |
32 |
4-Methoxy
Coumarin |
-1.22 |
-0.58 |
-1.24 |
-1.12 |
-1.08 |
-0.41 |
33 |
5-Methoxy Coumarin |
-1.15 |
-0.67 |
-1.25 |
-1.21 |
-1.16 |
-0.42 |
34 |
6-Methoxy
Coumarin |
-1.15 |
-0.67 |
-1.25 |
-1.21 |
-1.16 |
-1.42 |
35 |
7-Methoxy
coumarin |
-1.19 |
-0.51 |
-1.27 |
-1.19 |
-1.26 |
-0.48 |
36 |
8-MethoxyCoumarin |
-1.19 |
-0.91 |
-1.27 |
-1.19 |
-1.28 |
-0.48 |
37 |
3- EthoxyCoumarin |
-1.14 |
-0.53 |
-1.18 |
-0.93 |
-0.99 |
-0.39 |
38 |
4-EthoxyCoumarin |
-1.09 |
-0.70 |
-1.15 |
-0.85 |
-1.14 |
-0.42 |
39 |
5-EthoxyCoumarin |
-1.15 |
-0.77 |
-1.22 |
-0.67 |
-1.18 |
-0.45 |
40 |
6-EthoxyCoumarin |
-1.09 |
-0.70 |
-1.15 |
-0.85 |
-1.14 |
-0.42 |
41 |
7-EthoxyCoumarin |
-1.15 |
-0.77 |
-1.22 |
-0.67 |
-1.18 |
-0.65 |
42 |
8-EthoxyCoumarin |
-1.11 |
-0.84 |
-1.21 |
-0.99 |
-1.17 |
-0.46 |
43 |
3-Nitro Coumarin |
-1.07 |
-0.67 |
-1.21 |
-0.99 |
-1.20 |
-0.47 |
44 |
4-Nitro Coumarin |
-1.15 |
-0.64 |
-0.94 |
-0.93 |
-1.42 |
-1.40 |
45 |
5-Nitro Coumarin |
-1.22 |
-0.58 |
-1.12 |
-1.03 |
-1.38 |
-0.48 |
46 |
6-Nitro Coumarin |
-1.21 |
-0.63 |
-1.24 |
-1.08 |
-1.22 |
-0.46 |
47 |
7-Nitro Coumarin |
-1.29 |
-0.66 |
-1.37 |
-1.10 |
-1.28 |
-0.54 |
48 |
8-Nitro Coumarin |
-1.06 |
-0.65 |
-0.96 |
-1.15 |
-1.13 |
-0.36 |
49 |
2oxo-2H-chromene-3-carbaldehyde |
-1.19 |
-0.84 |
-1.24 |
-0.76 |
-1.19 |
-0.42 |
50 |
2oxo-2H-chromene-4-carbaldehyde |
-1.36 |
-0.94 |
-1.15 |
-0.66 |
-1.46 |
-0.48 |
51 |
2oxo-2H-chromene-5-carbaldehyde |
-1.21 |
-0.84 |
-1.12 |
-0.82 |
-1.40 |
-0.46 |
52 |
2oxo-2H-chromene-6-carbaldehyde |
-1.26 |
-0.78 |
-1.29 |
-0.94 |
-1.40 |
-0.461 |
53 |
2oxo-2H-chromene-7-carbaldehyde |
-1.29 |
-0.71 |
-1.35 |
-1.01 |
-1.44 |
-0.50 |
54 1 2 3 |
2oxo-2H-chromene-8-carbaldehyde Phytoconstituents Isofraxidin Scopoletin Umbilliserone |
-1.21 -0.88 -1.00 -1.31 |
-0.87 -0.34 -0.65 -1.10 |
-1.25 -0.76 -0.95 -1.18 |
-1.01 -0.76 -0.81 -0.62 |
-1.45 -0.94 -1.16 -139 |
-0.51 -0.06 -0.24 -0.40 |
Docking Analysis:
The docking scores were obtained
for the designed coumarin derivatives against aromatase receptor and the scores
are as given in Table .3
Table 3. Docking scores for 54 novel proposed analogues of
coumarin by using Arguslab 4.0.1
Sl No: |
Substitution |
Docking Score (kcal/mol) |
1 |
3-Bromo Coumarin |
-9.7 |
2 |
4- Bromo Coumain |
-9.7 |
3 |
5-Bromo Coumarin |
-9.6 |
4 |
6-Bromo Coumarin |
-9.6 |
5 |
7-Bromo Coumarin |
-9.2 |
6 |
8-Bromo Coumarin |
-9.5 |
7 |
3-Chloro
Coumarin |
-9.4 |
8 |
4-Chloro
Coumarin |
-8.9 |
9 |
5-Chloro
Coumarin |
-9.7 |
10 |
6-Chloro Coumarin |
-9.3 |
11 |
7-Chloro
Coumarin |
-9.2 |
12 |
8-Chloro
Coumarin |
-9.4 |
13 |
3- Fluoro Coumarin |
-9 |
14 |
4-Fluoro
Coumarin |
-8.4 |
15 |
5- Fluoro
Coumarin |
-8.9 |
16 |
6- Fluoro
Coumarin |
-8.6 |
17 |
7- Fluoro
Coumarin |
-8.8 |
18 |
8- Fluoro
Coumarin |
-8.9 |
19 |
3-Iodo Coumarin |
-9.8 |
20 |
4-Iodo Coumarin |
-9.4 |
21 |
5-Iodo Coumarin |
-9.5 |
22 |
6-Iodo Coumarin |
-9.6 |
23 |
7-Iodo Coumarin |
-9.1 |
24 |
8-Iodo Coumarin |
-9.1 |
25 |
3-Hydroxy
Coumarin |
-8.6 |
26 |
4-Hydroxy
Coumarin |
-8.3 |
27 |
5-Hydroxy
Coumarin |
-8.2 |
28 |
6-Hydroxy
Coumarin |
-8 |
29 |
7-Hydroxy
Coumarin |
-7.8 |
30 |
8-Hydroxy
Coumarin |
-8.2 |
31 |
3-Methoxy
Coumarin |
-8 |
32 |
4-Methoxy
Coumarin |
-8.29 |
33 |
5-Methoxy
Coumarin |
-8.34 |
34 |
6-Methoxy Coumarin |
-7.4 |
35 |
7-Methoxy Coumarin |
-7.8 |
36 |
8-Methoxy Coumarin |
-8.2 |
37 |
3- Ethoxy Coumarin |
-9.1 |
38 |
4-Ethoxy Coumarin |
-8.2 |
39 |
5-Ethoxy Coumarin |
-8.1 |
40 |
6-Ethoxy Coumarin |
-8.3 |
41 |
7-Ethoxy Coumarin |
-8.2 |
42 |
8-Ethoxy Coumarin |
-8.1 |
43 |
3- Nitro Coumarin |
-8.7 |
44 |
4- Nitro Coumarin |
-8.4 |
45 |
5- Nitro Coumarin |
-7.93 |
46 |
6- Nitro Coumarin |
-7.94 |
47 |
7- Nitro Coumarin |
-8.32 |
48 |
8- Nitro Coumarin |
-8.64 |
49 |
2oxo-2H-chromene-3-carbaldehyde |
-8.40 |
50 |
2oxo-2H-chromene-4-carbaldehyde |
-8.25 |
51 |
-8.69 |
|
52 |
2oxo-2H-chromene-6-carbaldehyde |
-8.07 |
53 |
2oxo-2H-chromene-7-carbaldehyde |
-8.27 |
54 |
2oxo-2H-chromene-8-carbaldehyde |
-8.51 |
55 |
Gefitinib(standard drug) |
-8.9 |
The docking scores were obtained
for the phytoconstituents having coumarin nucleus against aromatase receptor
and the scores are as given in Table.
4
Table.
4 Docking scores of phytoconstituents having coumarin nucleus using argus lab
4.0.1
Sl. No |
Phytoconstituent |
Docking Score(Kcal/mol) |
1 |
Isofraxidin |
-6.8 |
2 |
Scopoletin |
-7.16 |
3 |
Umbillierone |
-8.4 |
It was observed that among bromine substituted coumarins, 3-bromo
coumarin and 4-bromo coumarin showed best docking score (Fig. 2 and 3)
Fig.
2-bromo coumarin
Fig. 3 bromo coumarin
Among the chlorine-substituted coumarin 5-chloro coumarin shows
best docking score (fig.4)
Fig.4-chloro coumarin
Among the fluorine substituted coumarin 3- Fluoro coumarin showed
best docking score (fig.5)
Fig.5-
Fluoro coumarin
Among the iodine substituted coumarin 3-iodo coumarin showed best
docking score (fig.6)
Fig.6-
iodo coumarin
Among the hydroxyl substituted coumarin 3-hydroxy coumarin showed
best docking score (fig.7)
Fig.7-hydroxy
coumarin
Among the methoxy substituted
coumarin 5-methoxy coumarin showed best docking score (fig.8)
Fig.8-methoxy
coumarin
Among the ethoxy
substituted coumarin 3-ethoxy coumarin showed best docking score (fig.9)
Fig.9-ethoxy
coumarin
Among the nitro substituted coumarin 3-nitro coumarin showed best
docking score (fig.10)
Fig.10
3-nitro coumarin
Among the aldehyde substituted coumarin 2 oxo 2H –chromene- 5
carbaldehyde showed best docking score (fig.11)
Fig.11
2oxo-2H-chromene-5 carbaldehyde
Among the fifty four compounds
nineteen designed analogues of coumarin shows good docking score compared to
the reference drug Gefitinib, which is a drug used in the treatment of breast
cancer. Among 19 derivatives 3-iodo
coumarin showed best docking score than the reference drug gefitinib.
CONCLUSION:
The docking studies conducted in coumarin for its anti cancer
properties was successful and from that we came to a conclusion that coumarin
derivatives with iodine substitution at the third position of the heterocyclic
ring showed good docking score compared to the standard drug gefitinib and three phytoconstituent having coumarin
pharmacophore. From the present study we could also finalise that the
substitutions at the third position of coumarin ring with several electron
withdrawing groups such as bromo, fluoro, and nitro and electron releasing
group such as hydroxyl substitution demonstrate best affinity with the
aromatase receptors. The phytoconstituents of coumarin shows less docking score
as compared with these ligands.
ACKNOWLEDGEMENTS:
We are thankful to Department of Chemistry, Amrita School
of Pharmacy, Amrita Viswa
Vidyapeetham University, for
providing necessary facilities for the study.
REFERENCES:
1. P.K Jain,
Himanshu Joshi. Coumarin: chemical and pharmacological profile. Journal Of
Applied Pharmaceutical Science 2012; 2
supp 6: 236-240
2. Aoife Lacy and
Richard O’Kennedy. Studies on Coumarins and Coumarin - Related Compounds to
Determine their Therapeutic Role in the Treatment of Cancer. Current
Pharmaceutical Design 2004; 10: 3797-3811.
3. F. Borges1, F.
Roleira, N. Milhazes and L. Santana and E. Uriarte. Simple Coumarins and
Analogues in Medicinal Chemistry: Occurrence, Synthesis and Biological
Activity. Current Medicinal Chemistry 2005; 12: 887-916
4. S. Mirunalini, M.
Krishnaveri: Coumarin: A Plant Derived
Polyphenol With Wide Biomedical
Applications. International Journal of Pharma Tech Research, 2011; 3 supp 3
:1693-1696
5. R.M Patel, R.N
Sharma and N.J Patel. In-vitro Cytotoxic Screening of 4 Methyl-2h-chromen-2-one
derivatives against Hep 2 cell line. Asian
Journal of Biochemical and Pharmaceutical Research2011; 1 suppl 2:2231-2560
6. K.N. Venugopala,
V. Rashmi, and B. Odhav. Review on Natural Coumarin Lead Compounds for Their
Pharmacological Activity. BioMed Research International, 2013;
7. Adriana Basile,
Sergio Sorbo , Vivienne Spadaro , Maurizio Bruno, Antonella Maggio, Nicoletta
Faraone and Sergio Rosselli. Antimicrobial and Antioxidant Activities of
Coumarins from the Roots of Ferulago
campestris (Apiaceae). Molecules 2009; 14: 939-952
8. Bhatnagar A.,
Sharma P. K., Kumar N, Dudhe R. A review on “Recent advances in Coumarin
derivatives with their multidisciplinary actions”. Scholars Research
Library,2010; 2 suppl 4:297-306
9. Batra Nikhil,
Batra Shikha, Pareek Anil, Nagori Badri Prakash. Diverse Pharmacological Activities
of 3-Substituted coumarins. International Research Journal of Pharmacy 2012.; 3
suppl 7:2230 -8437
10. Mohd. Mudassir
Husain, Rajeev. Vibrational Spectra and Electronic Structural Studies of Some
Coumarins. Internatioal Journal of Research in Engineering and Sciences, 2013;1
supp 3: 2320-9364
11. Rajesh. N. Gacche
and Sharad. G. Jadhav. Anti oxidant Activities And Cytotoxicity of selected
coumarin derivatives : preliminary Results of a Structural -Activity Relationship
Study using computational
Journal. Journal of Experimental And Clinical Medicine 2012; 3 suppl
4:165-169
12. Deepthy Chandran,
Leena. K. Pappachen, Manju Prathap, Jinsha.G. Insilico Drug Design And
Molecular Docking Studies Of
Some Novel Benzothiazole Derivatives
As Anti-Cancer And Anti-inflammatory agents. International
Journal Of Pharmacy And Pharmaceutical Sciences 2014;6 suppl 2:203-208.
13. Sadia rahman, Muhammad
Ikkram, Robert J Baker, Muhammad Z
ubair, Effat Azad, Soyoung Min, Kashif Riyas, K.H Mok, Saeed-ur Rahman.
Synthesis, characterization, in –vitro
Anti- microbial and U2OS tumoricidal activities of different coumarin
derivatives. Chemistry Central Journal, 2013;7:68
14. Koneni V.
Sashidhara, Srinivasa Rao Avula, Komal Sharma, Gopala Reddy Palnati and
Surendar Reddy Bathula. Discovery of coumarin-monastrol hybrid as potential
antibreast tumor-specific agent. European Journal Of Medicinal Chemistry,201; 60:120-127
15. Qiong Gao, Neill
Patani, Anita K. Dunbier, Zara Ghazoui , Marketa Zvelebil, Lesley-Ann
Martin. Effect of Aromatase Inhibition
on Functional Gene Modules in Estrogen Receptor–Positive Breast Cancer and
Their Relationship with Antiproliferative Response. Clinical Cancer Research,
201;20 suppl 2:2484-2494.
16. Shahnawaz Ahmad,
Amit Chattree , Sikander Dar. In Silico, Study of Flavonoids and their
potential application as Anti-Cancer Agents. International Journal of Science and
Research, 2012; 11 Suppl 3:586-589.
Received on 24.10.2015
Modified on 04.11.2015
Accepted on 21.11.2015
© RJPT All right reserved
Research J. Pharm. and Tech. 8(12): Dec.,
2015; Page 1673-1678
DOI: 10.5958/0974-360X.2015.00302.9